Encompass Health Co. (NYSE:EHC) Shares Bought by Vestcor Inc

Vestcor Inc grew its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 173.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 57,879 shares of the company's stock after purchasing an additional 36,721 shares during the period. Vestcor Inc owned approximately 0.06% of Encompass Health worth $5,593,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in EHC. SG Americas Securities LLC purchased a new stake in shares of Encompass Health in the 2nd quarter worth about $2,204,000. Los Angeles Capital Management LLC boosted its position in shares of Encompass Health by 532.4% in the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company's stock worth $4,860,000 after buying an additional 42,338 shares in the last quarter. Pathstone Holdings LLC raised its stake in Encompass Health by 54.5% in the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company's stock valued at $2,032,000 after purchasing an additional 7,412 shares during the last quarter. Deerfield Management Company L.P. Series C acquired a new position in Encompass Health in the 2nd quarter valued at about $541,000. Finally, Meeder Asset Management Inc. raised its stake in Encompass Health by 43.8% in the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company's stock valued at $6,417,000 after purchasing an additional 20,242 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Stock Down 0.4 %

Shares of Encompass Health stock traded down $0.36 on Tuesday, hitting $101.29. 484,721 shares of the company's stock traded hands, compared to its average volume of 639,140. The stock has a market cap of $10.20 billion, a P/E ratio of 24.47, a PEG ratio of 1.36 and a beta of 0.86. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm's 50-day moving average is $99.07 and its 200 day moving average is $92.29. Encompass Health Co. has a 52-week low of $64.38 and a 52-week high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business's revenue was up 11.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.86 EPS. Equities analysts anticipate that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's dividend payout ratio is currently 16.43%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on EHC shares. Truist Financial reaffirmed a "buy" rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Barclays upped their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a research note on Tuesday, October 29th. UBS Group upped their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research note on Wednesday, September 25th. Royal Bank of Canada increased their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. Finally, KeyCorp increased their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Encompass Health presently has a consensus rating of "Buy" and an average price target of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.